BUSINESS WIRE)-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and ...
News
- Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125
- Xenon Pharmaceuticals: Q1 Earnings Snapshot
The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share. The gene therapy biotech company ...
- Former SA City Manager Sheryl Sculley moves to Austin
Sculley will still keep an office in downtown San Antonio, remain on the Texas Biomedical Research Institute board of trustees, continue her consulting ...
- This technology company will be one of the Mexican representatives in the Startup World Cup
The top ten ranked startups were: Getin, Co-Co Connecting Company, VU Security, SCORCE, PAMIB, Neptunus Biotech, tBooks, Kradac, WeeSign ...
- Review: Stacey Abrams writes a legal-political thriller
Keene soon finds herself the key figure in the planned merger of an American biotech company and an Indian genetics company. At stake, a ...